Diagnostic yield of repeat testing for SARS-CoV-2: Experience from a large health system in Los Angeles
Objective: To determine the diagnostic yield of repeat testing for SARS-CoV-2. Methods: A retrospective analysis was performed of all SARS-CoV-2 test results within the UCLA Health System between March 9th and April 29th, 2020. All patients with repeat test results were identified, and those with discordant results were reviewed. Results: Between March 9th and April 29th, there were 10,165 SARS-CoV-2 test results, of which 630 (6.2%) were positive. Among the 904 patients with repeat test results, 808 (89.4%) were initially negative, and 96 (10.6%) were initially positive. Among the 808 patients with an initial negative test, 15 (1.9%) subsequently tested positive. Eleven cases with an initial negative SARS-CoV-2 test and without a known prior positive SARS-CoV-2 test were reviewed; 6 were employed as healthcare workers, and 10 were positive on the second test. Conclusions: We found a low diagnostic yield of repeat testing for SARS-CoV-2 in our health system. Repeat testing might prove useful in certain clinical scenarios, such as in healthcare workers, when symptoms develop after a negative test, and in hospitalized patients with a high clinical suspicion of COVID-19..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:100 |
|---|---|
| Enthalten in: |
International Journal of Infectious Diseases - 100(2020), Seite 298-301 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Paul C. Adamson [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
COVID-19 |
|---|
| doi: |
10.1016/j.ijid.2020.08.048 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ013578006 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ013578006 | ||
| 003 | DE-627 | ||
| 005 | 20230310055432.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijid.2020.08.048 |2 doi | |
| 035 | |a (DE-627)DOAJ013578006 | ||
| 035 | |a (DE-599)DOAJe8e2e07b754b4ea4a179ab2411bc3643 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC109-216 | |
| 100 | 0 | |a Paul C. Adamson |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Diagnostic yield of repeat testing for SARS-CoV-2: Experience from a large health system in Los Angeles |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Objective: To determine the diagnostic yield of repeat testing for SARS-CoV-2. Methods: A retrospective analysis was performed of all SARS-CoV-2 test results within the UCLA Health System between March 9th and April 29th, 2020. All patients with repeat test results were identified, and those with discordant results were reviewed. Results: Between March 9th and April 29th, there were 10,165 SARS-CoV-2 test results, of which 630 (6.2%) were positive. Among the 904 patients with repeat test results, 808 (89.4%) were initially negative, and 96 (10.6%) were initially positive. Among the 808 patients with an initial negative test, 15 (1.9%) subsequently tested positive. Eleven cases with an initial negative SARS-CoV-2 test and without a known prior positive SARS-CoV-2 test were reviewed; 6 were employed as healthcare workers, and 10 were positive on the second test. Conclusions: We found a low diagnostic yield of repeat testing for SARS-CoV-2 in our health system. Repeat testing might prove useful in certain clinical scenarios, such as in healthcare workers, when symptoms develop after a negative test, and in hospitalized patients with a high clinical suspicion of COVID-19. | ||
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 RT-PCR | |
| 650 | 4 | |a Diagnosis | |
| 650 | 4 | |a Diagnostic testing | |
| 653 | 0 | |a Infectious and parasitic diseases | |
| 700 | 0 | |a David Goodman-Meza |e verfasserin |4 aut | |
| 700 | 0 | |a Tara Vijayan |e verfasserin |4 aut | |
| 700 | 0 | |a Shangxin Yang |e verfasserin |4 aut | |
| 700 | 0 | |a Omai B. Garner |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t International Journal of Infectious Diseases |d Elsevier, 2015 |g 100(2020), Seite 298-301 |w (DE-627)DOAJ000043923 |x 18783511 |7 nnns |
| 773 | 1 | 8 | |g volume:100 |g year:2020 |g pages:298-301 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijid.2020.08.048 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/e8e2e07b754b4ea4a179ab2411bc3643 |z kostenfrei |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1201971220306780 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1201-9712 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 100 |j 2020 |h 298-301 | ||